BI
NKGNW

Bulldog Investors’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Bulldog Investors’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,000
Closed -$7.89K – 188
2023
Q3 		$7.89K Hold
20,000
– – ﹤0.01% 143
2023
Q2 		$3.8K Hold
20,000
– – ﹤0.01% 176
2023
Q1 		$2.8K Hold
20,000
– – ﹤0.01% 223
2022
Q4 		$1.7K Buy
+20,000
New +$1.68K ﹤0.01% 246

Other funds holding NKGNW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

Bulldog Investors's NKGNW Position: Q4 2023 in Review

Bulldog Investors sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q4 2023, closing a stake of 20,000 shares — an estimated $7.89K sold.

Bulldog Investors first reported a position in NKGNW in Q4 2022 and held it in 4 quarters. The position peaked at $7.89K in Q3 2023. 31 funds tracked by Wall St. Rank hold NKGNW as of Q4 2023.

  • Bulldog Investors reported no remaining NKGen Biotech, Inc. Warrants position as of Q4 2023 after selling out during the quarter.
  • Bulldog Investors sold 20,000 NKGen Biotech, Inc. Warrants shares in Q4 2023, an estimated $7.89K.
  • Bulldog Investors first reported a position in NKGen Biotech, Inc. Warrants in Q4 2022 and held it in 4 quarters.
  • Bulldog Investors's NKGen Biotech, Inc. Warrants position peaked at $7.89K in Q3 2023.
  • 31 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q4 2023.

Based on Bulldog Investors's 13F filing for Q4 2023, filed 14 Feb 2024.